Mounjaro 5 mg / 0.6 ml QuickPen – 4 Doses

Active Ingredient

Tirzepatide

? Indications for Use

Mounjaro is used to improve blood sugar control in adults with type 2 diabetes, alongside a healthy diet and regular exercise.

? Dosage and Administration

• Initial Dose: 2.5 mg once weekly for 4 weeks.
• Maintenance Dose: After the first 4 weeks, increase to 5 mg once weekly.
• Dose Adjustments: The doctor may increase the dose by 2.5 mg to:
  • 7.5 mg, 10 mg, 12.5 mg, or 15 mg once weekly, depending on the patient’s response and needs.
• Administration Method:
  • Administered via subcutaneous injection in the abdomen, thigh, or upper arm.
  • Rotate injection sites with each dose to reduce skin irritation.

⚠ Potential Side Effects

• Low blood sugar (hypoglycemia) when used with other diabetes medications.
• Digestive issues such as nausea, vomiting, or diarrhea.
• Increased heart rate.
• Allergic reactions.

? Contraindications

• Known allergy to Tirzepatide or any of its ingredients.
• Personal or family history of medullary thyroid carcinoma (MTC).
• Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2).

⚠ Warnings and Precautions

• Regular kidney and liver function monitoring is recommended.
• Inform your doctor if you have a history of pancreatitis.
• Adjustments to other diabetes medications may be needed to reduce the risk of hypoglycemia.

? Storage Instructions

• Store in the refrigerator at 2 - 8°C.
• Keep away from light and out of reach of children.
• Do not freeze; if frozen, discard the product.

ℹ Additional Information

• Each pen contains 4 doses.
• Patients should be trained on proper pen usage.
• Discard the pen after using all 4 doses.

? Note

? Consult your doctor or pharmacist before using Mounjaro and read the package insert for detailed information.